Perinatal mortality and morbidity of SARS-COV-2 infection during pregnancy in European countries: Findings from an international study

Abstract

Data are presented as number (percentage) or as mean AE standard deviation (SD). * including diabetes, hypertension, or asthma. ** defined as body mass index of 30 or greater.

Worldwide beliefs among pregnant women on SARS-CoV-2 vaccine: a systematic review

“…There, evidence and guidance on how to manage obstetrics and gynecology patients during this period have been soon released and taken as example by other nations [2] , [3] , [4] , [5] , [6] , [7] , [8] , [9] , [10] , [11] , [12] , [13] , [14] , [15] . Notably, pregnant women were soon considered a population at increased risk for complications and more severe COVID-19 course [16] , [17] , [18] , [19] , [20] , [21] , [22] . Very soon, it appeared as the vaccination could have been one of the most useful solutions to counteract the pandemic, but historically pregnant women have not been included into vaccine trials [23] , and therefore uncertainty about its safety in this specific population opened a debate on the need to administer SARS-CoV-2 vaccine during pregnancy [24] , [25] , [26] , [27] , [28] ; indeed, counseling becomes of striking value in such a context [29] , [30] , [31] , [32] , [33] .…”

Maternal COVID-19 causing intrauterine foetal demise with microthrombotic placental insufficiency: a case report

“…While pregnant women have double the risk of getting infected with SARS-CoV-2 [ 1 ], they are also more prone to severe illness, requiring intensive care admission and invasive ventilation more often [ 2 – 4 ]. Emerging evidence from a multinational meta-analysis suggests that rates of stillbirth have increased during the pandemic in general [ 5 ], but studies about the real risk of miscarriage in women with SARS-CoV-2 infection are contradictory [ 6 – 8 ]. Recent reports suggested placental infection with SARS-CoV-2 as a confounding factor for foetal demise in the second trimester [ 9 ].…”